Drug interaction study for repinatrabit
Treatments studied
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests how repinatrabit interacts with common medications like birth control, metformin, and others. It helps doctors understand safe dosing and potential side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 35 BMI (body mass index).
- You are male or female who cannot become pregnant (for women, no childbearing potential).
- You are in good overall health with no serious medical conditions.
- You are willing to stay in the clinic for the study and do a follow-up phone call.
- You can give written permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new drug called RO7875913 in healthy volunteers to find the safest dose. It helps researchers understand how the drug works in the body before moving to studies in people with the disease.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
This trial checks how repinatrabit is processed in people with moderate liver problems or severe kidney problems compared to healthy adults. It helps doctors understand if the dose should be adjusted for these conditions.
This trial tests how a new medicine, HDM1002, interacts with four common drugs (repaglinide, atorvastatin, digoxin, rosuvastatin) in healthy and overweight adults. The results will help guide safe dosing for future patients.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This study tests how a drug called leramistat interacts with other medicines. It's for healthy adults who cannot get pregnant or make someone pregnant.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.